Continuous monitoring of immune biomarkers with wearable and implantable sensors
Official title: Continuous metabolite and protein profiling for immune monitoring
Funded at Texas Engineering Experiment Station · NIH-11400511 · Data updated 2026-11-12
A project to develop wearable and implantable sensors that continuously track immune system biomarkers in body fluids for real-time health monitoring.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | September 21, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $362,570 |
| NIH project number | 5R35GM147568-05 |
| Project ID | NIH-11400511 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with immune-related conditions or at risk for immune dysregulation who could benefit from continuous biomarker monitoring.
✕Less likely to help
People who do not require continuous immune monitoring or who cannot use wearable/implantable sensors may not benefit.
What this research studies
This grant aims to create biosensors that can nonstop measure biochemical markers, like cytokines, in the body to help doctors track immune-related conditions. It focuses on overcoming current sensing challenges so measurements can be accurate over minutes to days without frequent lab tests. The work combines wearable devices, miniaturized implants, and advanced bioelectronics to provide ongoing information about the body’s immune status. The goal is to enable personalized care by sharing real-time data with clinicians and patients. Please note: participants would contribute via use of sensors or samples if required by the study design.
Why it matters
Potential benefit: If successful, patients could receive continuous, point-of-care immune monitoring data that may inform treatment decisions in real time.
How similar studies have gone: Previous biosensor approaches exist, but continuous, clinically viable biochemical monitoring remains an area with limited proven long-term success.
Where this research is happening
-
Texas Engineering Experiment Station
College Station, United States Active
Researchers
- Principal investigator: Tian, Limei — Texas Engineering Experiment Station
- Study coordinator: Tian, Limei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.